SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is a major topic as investors anticipate explosive earnings driven by insatiable AI demand for its high-bandwidth memory, with recent analyst upgrades reflecting a perceived "seller's market." Community discussion highlights a potential competitive edge for Micron amidst geopolitical tensions impacting South Korean memory chip rivals.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is experiencing extreme volatility and a potential short squeeze, driven by escalating geopolitical tensions threatening global oil supply, while investors are actively debating the impact of a recent share offering.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is highly volatile amidst escalating Middle East tensions, fueled by reports of attacks on US assets and military responses. Community sentiment is sharply divided between those predicting a broader market correction and others aggressively buying dips, with discussions focusing on potential oil market disruption and wider global instability.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid widespread discussion and highly polarized views surrounding recent U.S. military actions in Iran, with many in the community debating if the moves are a strategic necessity or a political diversion from other issues like the Epstein files, causing concerns about escalating global conflicts and economic impacts.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending following a beat on revenue and a robust outlook, sparking community debate over its high valuation versus its leadership in securing rapidly expanding AI deployments, which the CEO emphasizes as a major growth opportunity for the cybersecurity firm.

Texxon Holding Ltd. provides supply chain management services in East China. Its services include the sale of plastic, chemical raw materials, and other plastic raw materials. Its products are used in fabrics, coastings, resins, beverage packing, other downstream products, pipelines and pipes used in infrastructure, daily or food grade packing and agriculture membranes. The company was founded on January 20, 2022 and is headquartered in Shanghai, China.

Texxon Holding Ltd

Texxon Holding Ltd (NPT), a low-float Chinese stock, is trending with extreme volatility and massive volume driven by its recent IPO and subsequent over-allotment option exercise. The community is buzzing about significant price spikes and frequent trading halts, with many speculating on further gains while others voice concerns about its "pump and dump" characteristics.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is generating significant discussion following its Q4 earnings, where a wider-than-expected loss and high burn rate clash with the monumental achievement of 100% FAA Means of Compliance for its Midnight aircraft. Bulls view this as a critical de-risking milestone for its 2026 passenger flight target and highlight strong liquidity, while bears emphasize ongoing financial concerns, high expenses, and potential dilution.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea Ltd. is trending following its Q4 earnings report, which showed robust revenue growth and optimistic Shopee GMV guidance, but was overshadowed by an EPS miss and increasing credit loss provisions. The community is actively debating whether the ensuing sharp sell-off is an overreaction to short-term pressures or a valid concern given rising competition and profitability challenges in its diverse e-commerce and digital finance segments.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market grapples with escalating Middle East tensions and US military actions to secure shipping in the Strait of Hormuz. The community is sharply divided, with many expressing frustration over consistent "V-shaped" rallies and perceived market manipulation, while others highlight the tech-heavy index's remarkable resilience to geopolitical uncertainty.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to significant volatility, initially sparked by reports of its inclusion on a U.S. Pentagon list of military-linked firmsa designation swiftly withdrawn and widely perceived by the community as manipulative 'fake news.' Compounding investor sentiment is the ongoing uncertainty surrounding its earnings release date, while discussions also highlight Alibaba's latest advancements in AI, particularly with its upgraded Qwen 3.5 model and robotics AI initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Moderna Stock Jumps 10% After Hours: Here's Why

Moderna shares are rising in Tuesday's after-hours session after the company announced it reached a settlement agreement.read more...

Moderna Reaches $2.25 Bln Patent Settlement With Genevant, Arbutus

(RTTNews) - Moderna, Inc. (MRNA) has agreed to pay $950 million upfront and up to an additional $1.3 billion under a $2.25 billion global settlement with Genevant Sciences, a subsidiary of Roivant...

<ul class="summary-bullets"><li>Moderna said that the settlement provides certainty going forward for the company’s entire infectious disease portfolio and its future vaccine pipeline with no future royalties owed.&nbsp;</li><li>Under the deal, Moderna will pay Arbutus and Genevant $950 million in the third quarter of 2026.</li><li>The remaining $1.3 billion payout is subject to further litigation.</li></ul>Shares of vaccine maker Moderna (MRNA) rallied after hours on Tuesday after the company announced that it has entered into an up to $2.25 billion settlement with Genevant Sciences and Arbutus Biopharma.The settlement resolves all enforcement actions involving Moderna’s use of Genevant’s and Arbutus’ Lipid Nanoparticle (LNP) delivery technology in its COVID-19 vaccine Spikevax as well as respiratory syncytial virus (RSV) vaccine mRESVIA. The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://feeds.issuerdirect.com/news-release.html?newsid=5178901572623640&amp;symbol=MRNA">said</a> that the settlement provides certainty going forward for the company’s entire infectious disease portfolio and its future vaccine pipeline with no future royalties owed.<a href="https://stocktwits.com/symbol/ABUS">Shares of Arbutus</a> fell 8% after hours at the time of writing while shares of Genevant’s parent <a href="https://stocktwits.com/symbol/ROIV">Roivant Sciences</a> gained nearly 1%. Meanwhile, shares of MRNA rallied 11%.<h2 class="st-heading-2">Settlement Agreement</h2>Under the deal, Moderna will pay Arbutus and Genevant $950 million in the third quarter of 2026. The remaining $1.3 billion is subject to further litigation. If Moderna prevails in the litigation, no further payments will be due but if it doesn't, it will have to make an additional payment of up to $1.3 billion."Resolving this legacy matter from our pandemic response removes uncertainty and allows us to turn our full focus to Moderna's exciting near-term future," said Moderna CEO Stéphane Bancel.The company now expects to end the year with $4.5 to $5.0 billion in cash and cash equivalents. The total projected liquidity available to the company at the end of 2026 will be $5.4 to $5.9 billion, it added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around MRNA rose from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘low’ levels.<a href="https://stocktwits.com/symbol/MRNA">MRNA shares</a> have gained nearly 65% over the past 12 months. Meanwhile, ABUS and ROIV added 37% and 174%, respectively.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/autozone-shares-dive-post-earnings-but-wells-fargo-sees-buying-opportunity/cZdeYkuRIPt">AutoZone Shares Dive Post-Earnings But Wells Fargo Sees A Buying Opportunity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration vials of vaccines for coronavirus (COVID-19). Vaccines from left to right, Moderna, Bimervax, Comirnaty and Pfizer BioNTech. (Photo Illustration by Marcos del Mazo/LightRocket via Getty Images)

MRNA Shares Rally After Hours On Inking Settlement Deal Over Vaccine Patent Row

The settlement resolves all enforcement actions involving Moderna’s use of Genevant’s and Arbutus’ LNP delivery technology in its COVID-19 vaccine Spikevax.

Equity

The settlement resolves all enforcement actions involving Moderna’s use of Genevant’s and Arbutus’ LNP delivery technology in its COVID-19 vaccine Spikevax.


Top Biotech Stocks To Watch Now - March 3rd

Danaher, Moderna, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop...

Biotech Stocks To Follow Today - March 2nd

Danaher, Moderna, and ImmunityBio are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop, and...

MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot

Moderna jumps 4% after EU panel backs mCombriax, its COVID-19-flu combo shot, with phase III data showing stronger immune response vs standalone vaccines.

Promising Biotech Stocks To Research - March 1st

Danaher, Vertex Pharmaceuticals, Moderna, argenex, United Therapeutics, ImmunityBio, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...

Biotech Stocks To Keep An Eye On - February 28th

Danaher, Vertex Pharmaceuticals, and Moderna are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop...

This Is What Whales Are Betting On Moderna

Promising Biotech Stocks To Consider - February 27th

Danaher, Vertex Pharmaceuticals, argenex, ImmunityBio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Software / SaaS

Cybersecurity

Cloud Infrastructure

AI / Semiconductors

Which beaten-down sector are you buying first?

Stocktwits

Stocktwits Polls

Moderna settled its worldwide COVID vaccine patent dispute with Arbutus and Genevant for $2.25 billion, securing its infectious disease portfolio from future royalties.

European regulators endorsed the company's first-to-market COVID-19 and influenza combination vaccine, signaling a significant validation and growth catalyst.

Excitement builds around the oncology pipeline, with 5-year data showing sustained efficacy for the personalized cancer vaccine partnered with Keytruda.

Aggressive price targets are emerging, with many expecting a significant short squeeze to push the stock toward $75-100+ after recent positive catalysts.

Current Price	$49.83
Prev Close	$52.85
Open	$50.45
Dividend Yield	0.00%
50-Day Moving Average	$41.10
Beta	1.28
Avg. Volume	10.34M
PE Ratio	-7.28

52-Week High	$55.20
52-Week Low	$22.28
Market Capitalization	$20.87B
EPS (Annual)	-$7.25
Price to Book	2.41
Revenue Per Employee	$413,617.02

MRNA
Moderna Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRNA News

MRNAModerna Inc